ArticleInternational journal of toxicology2022

Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™.

Jean G Sathish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.